Yamashita S, Melmed S
CJC-1295 is a modified GHRH analogue based on the same GRF 1-29 backbone as sermorelin, but with four amino acid substitutions (Ala2D-Ala, Asn8Gln, Ala15Ala(NMe), Leu27Leu(NMe)) that improve resistance to DPP-IV degradation
Genetic evidence for repurposing GLP-1 receptor agonists in chronic kidney disease and IgA nephropathy: Metabolic and anti-inflammatory pathways beyond glycaemic control
Besides, there is also the possibility of the allergic reactions may occur not with the active drug, but because of metacresol, an antimicrobial additive
It appears that Skye is only targeting 8% weight loss after 26 weeks with just nimacimab
The funding source had no input in the design, collection, data analysis and interpretation, or the writing of the manuscript